Navigation Links
Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
Date:10/1/2007

- Five-year Agreement

- Guaranteed Purchase Requirements - Good Faith Negotiations for Contract Manufacturing of DaySpring Core

Products

- Value Projected To Range Between $4.4M-7M Over Five Years

IRVING, Texas, Oct. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Pink Sheets: CARN) (http://www.CarringtonLabs.com) today announced it has formalized its previously announced multi-year supply and distribution term sheet with DaySpring Pharma, LLC (http://www.dayspringpharma.com). The previous announcement included a two-year term; the final, formal agreement has been extended to five years.

Under the terms of this agreement, Carrington will supply multiple prescription products based on Carrington's flagship DiaB(TM) and Radia(TM) brands to DaySpring for distribution into the physician market. Carrington's DiaB(TM) and Radia(TM) products have been developed specifically for diabetic wound care and for patients undergoing radiation therapy. In exchange for guaranteed volumes of these prescription products, DaySpring will receive market protection in the physician market. All products will contain Carrington's Acemannan Hydrogel(TM). The parties will also enter into good faith negotiations for the manufacture and supply of other DaySpring products.

"We are excited about the formal partnership with DaySpring. This relationship provides the platform to take our leading brands that include Acemannan Hydrogel(TM) into other healthcare markets outside hospitals, nursing homes, and home healthcare facilities," stated Doug Golwas, vice president of corporate sales and marketing for Carrington. "These products are a natural extension for DaySpring's sales force and channels to market. DaySpring currently markets to prescription health
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 05, 2015 The next implants ... received the CE mark (European) approval. The CE mark ... Trade Association (EFTA) and the European Union. Following the ... been granted to implants supplied by the Turkey-based company ... , Osimplant's Cervical Expandable Bladed HA PEEK Cage ...
(Date:3/4/2015)... Nev. , March 4, 2015 PDL BioPharma, Inc. ... adjusted conversion rate for the: , 3.75% Convertible ... 174.8506 shares of common stock per $1,000 principal amount or ... The conversion rate for the note is adjusted in connection ... on March 12, 2015, to all stockholders who own shares of ...
(Date:3/4/2015)... The UPMC Center for Health Security today ... Emerging Leaders in Biosecurity Initiative (ELBI). As part of ... of biosecurity, UPMC has selected 28 US and international ... backgrounds, including biological science, medicine, policy, the military, think ... the vision and support of the Defense Threat Reduction ...
(Date:3/4/2015)... USDM Life Sciences , a ... industry, hired David Blewitt as Vice President ... Services and Solutions at USDM Life Sciences , which ... maintaining compliance with government regulations worldwide. , For ... life sciences regulatory and IS compliance professional with extensive ...
Breaking Biology Technology:Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 3USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3
...  Stemline Therapeutics, Inc. today announced that Ivan Bergstein, MD, ... at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, ... Waldorf Astoria Hotel in New York City. ... Therapeutics, Inc. is a clinical stage biopharmaceutical company developing ...
... enters commercialization phase / Initial order of Sangui developed wound ... an initial order of Hemo2Spray, the Sangui developed wound spray, ... registered by the Mexican authorities in September this year. This ... and Sangui management is positive that an era of innovative ...
... assessing the safety and efficacy of hydroxyurea therapy in pediatric ... pre-operative transfusions for patients with SCD who undergo low- and ... Annual Meeting of the American Society of Hematology. ... by SCD, a serious disorder that causes normal red blood ...
Cached Biology Technology:Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference 2Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management 2Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 2Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 3Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 4Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 5Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 6Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease 7
(Date:3/2/2015)... Lithuania , March 2, 2015   Neurotechnology ... technologies, today introduced the SentiGaze Software Development Kit ... to create applications that use off-the-shelf webcams to track ... user gazes at a monitor. Heatmaps can be used ... the effectiveness of online advertising. The SDK can also ...
(Date:2/23/2015)... Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT ... introduces a new groundbreaking payment method. Payment accounts may ... may only be accessed if both the speech (the ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... BLOOMINGTON, Ind. -- The ranges of species will have to ... and 2100 because the climate will change more than 100 ... according to a newly published study by Indiana University researchers. ... that the rate of future change in suitable habitat will ...
... mole rats ( Heterocephalus glaber ) live in a ,hive, ... reproducing males. The rest of the mole rats in the ... not an easy task when you are virtually blind ... published in BioMed Central,s open access journal BMC Evolutionary ...
... become embedded in genomic DNA, which contains the complete ... for cells. It is known that ribonucleotides in DNA ... genomic instability and altered DNA metabolism, but not much ... A new study provides a mechanistic explanation of how ...
Cached Biology News:Study finds climate changes faster than species can adapt 2Study finds climate changes faster than species can adapt 3Bottom of the swimming league: Naked mole rat sperm 2Study identifies mechanisms cells use to remove bits of RNA from DNA strands 2
Geneticin Selective Antibiotic liquid...
Immunogen: Extract of pigmented melanoma metastases from lymph nodes. Storage: -20 C, Avoid Freeze/Thaw Cycles...
alpha N-catenin (C-19)...
... ZMD.257. Immunogen: Synthetic peptide derived from ... Connexin 36 protein This peptide sequence ... generate another Zymed polyclonal Connexin 36 antibody ... mouse Connexin 36. Reactivity: Mouse (positive ...
Biology Products: